Wordt geladen...
Ursodeoxycholic acid for primary biliary cirrhosis
BACKGROUND: Ursodeoxycholic acid is administered to patients with primary biliary cirrhosis, a chronic progressive inflammatory autoimmune‐mediated liver disease with unknown aetiology. Despite its controversial effects, the U.S. Food and Drug Administration has approved its usage for primary biliar...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2012
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045744/ https://ncbi.nlm.nih.gov/pubmed/23235576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000551.pub3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|